Lawmakers call for aggressive action to curb UnitedHealth

'It's just absolutely punishing our community so this big corporation can make even more profits,' said one House representative

December 23, 2024 Check out STAT+

Sponsored By

Searching for the perfect gift? Get your first three months of STAT+ for $10. Subscribe now, and thanks for reading as always.

Sophie Park for STAT Gender-affirming surgery disappeared from the U.S. for decades. Now the field is fighting to keep its gains From 2016-2019, U.S. gender-affirming surgeries tripled. Trans community fights political headwinds to maintain progress, acceptance, access to surgery. By Theresa Gaffney STAT+ | FDA designates Neuralink brain implant, infectious disease tests as 'breakthroughs' The FDA granted breakthrough designation to at least nine medical technology companies between mid-September and December, STAT found. By Lizzy Lawrence STAT+ | PhRMA dues fell almost $100 million as major drugmakers exited PhRMA's dues declined after the big drugmakers AbbVie, AstraZeneca, and Teva left the lobbying group. By Rachel Cohrs Zhang STAT+ | Lawmakers call for curbs on UnitedHealth's growing empire Democratic lawmakers urge antitrust breakup of business empire they say is undermining competition, corrupting Medicare, and hurting patients By Casey Ross, Bob Herman, Tara Bannow, and Lizzy Lawrence STAT+ | A tough year for health insurance stocks as patients get more care This week in healthcare news: A Medicare Advantage settlement, insurer stocks stumble, and lawmakers call to rein in UnitedHealth Group. By Bob Herman STAT+ | As Congress waffles on AI, state legislatures step up to fill the void A patchwork of state laws governing artificial intelligence could create a regulatory labyrinth for tech developers and health systems. By Brittany Trang Stuart Isett for Fortune Brainstorm Health 'We just dismiss people like RFK Jr.': Infectious disease expert on how — and how not — to rebuild trust In a Q and A, Michael Osterholm acknowledges concerns about vaccines and encourages more openness on risks as well as benefits. By Isabella Cueto

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser